Epidemiology of tuberculosis and levels of vitamin D in Australia: person, place and time
Authors: Jennifer H MacLachlan and Benjamin C Cowie
Published online: 18 November 2013
To the Editor: We recently reported the impact of latitude on seasonality of tuberculosis in Australia, with greater cyclic variation in southern parts of the continent.1 We hypothesise that this seasonality is partly determined by differences in ultraviolet radiation exposure and subsequent vitamin D synthesis.1-3
Vitamin D deficiency (serum 25-hydroxyvitamin D levels below 50 nmol/L)3 has become a significant public health concern in Australia. Australians with darker skin, including some migrants and Aboriginal and Torres Strait Islander people, are at particular risk of both vitamin D deficiency3,4 and tuberculosis.1,5
Similar to our findings regarding tuberculosis incidence,1 a recent Australian study found that vitamin D deficiency was most prevalent in spring and that risk was highest for residents in major cities, people from socioeconomically disadvantaged areas, and those aged 20–39 and ≥ 80 years.2 These factors also apply to tuberculosis, including the age distribution (Box).
The correlations between seasonal variations in, and risk factors for, vitamin D deficiency and tuberculosis in Australia reinforce the ecological association between these conditions. Such associations cannot determine causality; but their consistency argues that guidelines should consider the potential impact of vitamin D deficiency on people at greatest risk of tuberculosis.1 The increased risk of tuberculosis conferred by vitamin D receptor polymorphisms supports a causal role for vitamin D deficiency in active tuberculosis.6
Despite increasing observational data regarding vitamin D deficiency and risk of tuberculosis, evidence supporting vitamin D supplementa-tion to reduce this risk is lacking.6 However, given the broader potential health impacts of vitamin D deficiency in high-risk populations, we support recent calls to increase vitamin D testing in these groups and to promote supplementation for those at greatest risk of both tuberculosis and vitamin D deficiency, including migrants with darker skin.3
Serum 25-hydroxyvitamin D levels of at least 50 nmol/L at the end of winter have been recommended for optimal bone and muscle function,3 with supplementation continued into spring to avert depletion.2 This seasonal focus on ensuring adequate vitamin D levels in people at risk of both vitamin D deficiency and tuberculosis could also reduce the seasonal peak of disease each spring, particularly in the southern states of Australia.1
Age distribution of tuberculosis (TB) notifications* and vitamin D levels† in Australia

25-OHD = 25-hydroxyvitamin D. * Source: National Notifiable Diseases Surveillance System. † Source: Boyages and Bilinski.2
Competing interests
References
- MacLachlan JH, Lavender CJ, Cowie BC. Effect of latitude on seasonality of tuberculosis, Australia, 2002–2011. Emerg Infect Dis 2012; 18: 1879-1881. 0_CHDECJJA
- Boyages S, Bilinski K. Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clin Endocrinol (Oxf) 2012; 77: 515-523. 0_i1142915
- Nowson CA, McGrath JJ, Ebeling PR, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012; 196: 686-687. 0_i1142918
- Vanlint SJ, Morris HA, Newbury JW, Crockett AJ. Vitamin D insufficiency in Aboriginal Australians. Med J Aust 2011; 194: 131-134. 0_i1142921
- McBryde ES, Denholm JT. Risk of active tuberculosis in immigrants: effects of age, region of origin and time since arrival in a low-exposure setting. Med J Aust 2012; 197: 458-461. 0_i1142924
- Ralph AP, Lucas RM, Norval M. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis 2013; 13: 77-88. 0_i1142927
Watchful Waiting Compared With Immediate Antibiotics for Urban Aboriginal and Torres Strait Islander Children With Uncomplicated Acute Otitis Media (WATCH): A Non-Inferiority Randomised Controlled Trial
Jennifer S. Reath, Hasantha Gunasekera, Sanja Lujic, Amanda J. Leach, Letitia Campbell, Robyn Walsh, Tim Usherwood, Geoffrey K. Spurling, Claudette A. Tyson, Deborah A. Askew, Kelvin Kong, Chelsea J. Watego, Peter Morris, Wendy Hu, Penelope A. Abbott
Beds Still Burning: Suicide Should Not Be in the Vocabulary of Children
Rudi Louis Taylor-Bragge
Weight Loss Medication Marketing and First Nations People: Disease Awareness or Corporate Profit?
Troy Walker, Simone Sherriff, Jennifer Browne
Beyond Mammography: Sovereignty and Relational Breast Care With Aboriginal and Torres Strait Islander Women
Devaleena Das, Jessica Gildersleeve, Amy Thomson, Aunty Gracelyn Smallwood, Lorelle Holland
Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress
Sophie Pitt, Ashlee Williams-Barnes, Ryan Dashwood, Keira Edwards, Paul Saunders
Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective
Bianca F. Middleton, Kristy Crooks, Kylie Taylor, Elizabeth Harwood, Katrina K. Clark, Caitlin Kent, Kelly McCrory, Marita Hefler, Jessica Kaufman, David N. Durrheim, Margie H. Danchin